Position in CLDX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,951,720
+$722,058 QoQ
Shares Held
79,326
+12.9% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. CLDX ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,951,720 | 79,326 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,229,662 | 70,292 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,808,041 | 66,570 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,391,681 | 92,450 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,602,317 | 127,878 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,431,635 | 78,878 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,635,797 | 143,878 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,577,011 | 164,078 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $7,019,982 | 189,678 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $9,463,311 | 225,478 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,075,090 | 52,322 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,786,653 | 64,922 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,101,401 | 32,461 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,646,480 | 45,761 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,462,982 | 55,261 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,339,750 | 47,661 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $988,380 | 36,661 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,514,615 | 73,829 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,408,392 | 62,329 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,365,142 | 62,329 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,502,425 | 44,929 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $470,710 | 22,850 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $287,328 | 16,400 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||